Deals

RevettMining Co. Raises $1.8M at 5% Premium from Urion Mining, Insiders

By |

RevettMining Company Inc. (RVM) announced that it has raised $1,799,998 in a Units (Common Stock + Warrants) transaction. The common stock was sold at $0.78 per share, an approximate 5% premium to the market price ($0.74) of RVM at deal announcement. A series of 1,153,845 24-Month Warrants with an exercise price of $1.00 per share (35.14% premium) was issued to the investors in this transaction. The investors include Urion Mining International B.V. and members of the Company's board of directors. Note that this Placement will fund in two tranches.

Deals

Codorus Valley Bancorp Raises $13M at 9% Discount via Sandler O’Neill

By |

Codorus Valley Bancorp, Inc. (CVLY) announced that it has raised $13,000,000 in a Common Stock transaction. The common stock was sold at $20.00 per share, an approximate 9% discount to the market price ($21.95) of CVLY at deal announcement. Sandler O'Neill & Partners, L.P. acted as the exclusive agent on the transaction. Issuer counsel was Rhoads & Sinon LLP. via PlacementTracker.

Deals

Generex Biotechnology Raises $2M in Conv Preferred at 25% Discount.

By |

Generex Biotechnology Corporation (GNBT) announced that it has raised $2,075,000 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.03 per share, an approximate 25% discount to the market price ($0.04) of GNBT at deal announcement. A series of 69,166,667 60-Month Warrants with an exercise price of $0.03 per share (25% discount) was issued to the investors in this transaction. The transaction is expected to close on March 27, 2014. via PlacementTracker.

Deals

Spherix Raises $4.4M at 16% Discount via Laidlaw

By |

Spherix Inc. (SPEX) announced that it has raised $4,446,081 in a Units (Common Stock + Warrants) transaction. The common stock was sold at $3.75 per share, an approximate 16% discount to the market price ($4.48) of SPEX at deal announcement. A series of 592,794 60-Month Warrants with an exercise price of $6.15 per share (37.28% premium) was issued to the investors in this transaction. Laidlaw & Company (UK) Ltd. acted as the exclusive agent on the transaction.